Loading clinical trials...
Loading clinical trials...
Is Less More? Dosing and Sequencing Effects of Cognitive Therapies for Anxiety and Depression
The investigators want to evaluate core components from cognitive behavioral psychotherapies (CBTs) with the aim of investigating dosing and combinatory effects on conditions of anxiety and depression.
In the present study, participants will be randomly assigned to one of four groups, receiving one or both treatment components under investigation, all over the course of six sessions of treatment. 1. It is hypothesized that both component A (Cognitive Restructuring) and component B (External Attention Allocation) will be efficient in reducing symptoms of depression and anxiety when delivered separately, both when delivered over 3 and 6 sessions. The difference between components as well as between the number of sessions on primary and secondary outcomes will be explored. 2. The combinatory effects, comparing the effect of receiving Component A subsequent to Component B and vice versa will be explored. 3. The process of change in both components will be explored. 4. Group differences in participants' experience of being the recipient of the components (either individually or combination) both qualitatively (free descriptions of their experience with using them) and quantitatively (questionnaires concerning the understanding and employment) will be explored. 5. The moderating effect of baseline characteristics including baseline symptomatology, diagnoses, personality functioning, and working alliance will be explored. 6. Potential harmful effects will be explored in each group.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
April 1, 2025
Primary Completion Date
June 30, 2027
Completion Date
December 31, 2027
Last Updated
April 10, 2025
180
ESTIMATED participants
Cognitive restructuring
BEHAVIORAL
Attention allocation
BEHAVIORAL
Lead Sponsor
University of Aarhus
NCT06377189
NCT06318962
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions